Eurofarma

Company Deals

Eurofarma Invests in Abcuro as Part of $100 Million Disruptive Startups and Biotech Initiative

Fineline Cube Sep 11, 2023

Brazil-based multinational company (MNC) Eurofarma has announced an investment in US immunotherapy developer Abcuro as...

Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Company Drug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

Company Drug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis

Company Drug

Bristol-Myers Squibb’s Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer